Recent Posts
- Naveris Receives Medicare Coverage for NavDx® Test
- Naveris Announces Two Peer-Review Publications Validating NavDx® Performance in Daily Clinical Practice
- Naveris Announces New Data Featuring NavDx® in Oral Highlight and Poster Presentations at Upcoming ASTRO and AAO-HNSF 2023 Meetings
- Mayo Clinic Collaborates with Naveris to Advance Precision Medicine in HPV-driven Head and Neck Cancer with NavDx in DART 2.0 Clinical Trial
- Naveris Collaborators Present Award-winning Abstract at ASTRO 2022 on Potential of NavDx to Inform Treatment Strategies in HPV-driven Cancers
Recent Comments